Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types
about
Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Glucosylceramide synthase inhi ...... with different mutation types
@en
Glucosylceramide synthase inhi ...... with different mutation types
@nl
type
label
Glucosylceramide synthase inhi ...... with different mutation types
@en
Glucosylceramide synthase inhi ...... with different mutation types
@nl
prefLabel
Glucosylceramide synthase inhi ...... with different mutation types
@en
Glucosylceramide synthase inhi ...... with different mutation types
@nl
P2093
P2860
P356
P1476
Glucosylceramide synthase inhi ...... with different mutation types
@en
P2093
A Mühlemann
M Garzotti
M R Probst
P M A Groenen
R W D Welford
P2860
P304
P356
10.1093/HMG/DDY248
P407
P577
2018-10-01T00:00:00Z